EUVIMEDEUVIMED entdecken
Übersichtsarbeit

PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact

Naiem T Issa, Sabine Obagi, Giovanni Damiani, Jimin Wang, Christopher G Bunick

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.9089 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Naiem T Issa und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Phosphodiesterase 4 Inhibitors, Skin Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphodiesterase 4 InhibitorsSkin DiseasesHumansAminopyridinesCyclic Nucleotide Phosphodiesterases, Type 4BenzamidesCyclopropanesPsoriasisTreatment OutcomeThalidomide

Substanzen

Phosphodiesterase 4 InhibitorsRoflumilastAminopyridinesCyclic Nucleotide Phosphodiesterases, Type 4BenzamidesCyclopropanesapremilastThalidomide

Zitieren

APA

Issa, N. T., Obagi, S., Damiani, G., Wang, J., & Bunick, C. G. (2025). PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9089

Vancouver

Issa NT, Obagi S, Damiani G, Wang J, Bunick CG. PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9089

BibTeX
@article{Issa2025,
  author = {Issa, Naiem T and Obagi, Sabine and Damiani, Giovanni and Wang, Jimin and Bunick, Christopher G},
  title = {PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.9089}
}
Kostenlos starten →